SO
BHVN

STRS Ohio’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

STRS Ohio’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,900
Closed -$1.65M – 2132
2022
Q3 		$1.65M Buy
10,900
+100
+0.9% +$14.8K 0.01% 647
2022
Q2 		$1.57M Buy
10,800
+2,900
+37% +$370K 0.01% 699
2022
Q1 		$936K Buy
7,900
+700
+10% +$87.3K ﹤0.01% 1081
2021
Q4 		$992K Sell
7,200
-3,200
-31% -$407K ﹤0.01% 1124
2021
Q3 		$1.44M Buy
10,400
+5,100
+96% +$637K 0.01% 877
2021
Q2 		$514K Buy
5,300
+3,100
+141% +$252K ﹤0.01% 1552
2021
Q1 		$150K Sell
2,200
-2,700
-55% -$218K ﹤0.01% 1857
2020
Q4 		$419K Buy
4,900
+500
+11% +$42.4K ﹤0.01% 1546
2020
Q3 		$286K Sell
4,400
-1,400
-24% -$91.8K ﹤0.01% 1581
2020
Q2 		$424K Buy
+5,800
New +$309K ﹤0.01% 1410
2019
Q3 		– Sell
-18,600
Closed -$814K – 2238
2019
Q2 		$814K Buy
+18,600
New +$1.05M ﹤0.01% 920
2018
Q1 		– Sell
-18,200
Closed -$491K – 1968
2017
Q4 		$491K Hold
18,200
– – ﹤0.01% 1329
2017
Q3 		$680K Buy
18,200
+15,300
+528% +$464K ﹤0.01% 1203
2017
Q2 		$72K Buy
+2,900
New +$66.8K ﹤0.01% 1716

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

STRS Ohio's BHVN Position: Q4 2022 in Review

STRS Ohio sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 10,900 shares — an estimated $1.65M sold.

STRS Ohio first reported a position in BHVN in Q2 2017 and held it in 14 quarters. The position peaked at $1.65M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • STRS Ohio reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • STRS Ohio sold 10,900 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $1.65M.
  • STRS Ohio first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 14 quarters.
  • STRS Ohio's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.65M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on STRS Ohio's 13F filing for Q4 2022, filed 26 Jan 2023.